nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP19A1—Betamethasone—ankylosing spondylitis	0.196	0.289	CbGbCtD
Melatonin—CYP1B1—Dexamethasone—ankylosing spondylitis	0.14	0.208	CbGbCtD
Melatonin—CYP19A1—Dexamethasone—ankylosing spondylitis	0.114	0.168	CbGbCtD
Melatonin—SLC22A8—Methotrexate—ankylosing spondylitis	0.0623	0.0922	CbGbCtD
Melatonin—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0616	0.0911	CbGbCtD
Melatonin—CYP2C19—Prednisone—ankylosing spondylitis	0.0478	0.0707	CbGbCtD
Melatonin—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0298	0.0441	CbGbCtD
Melatonin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0248	0.0367	CbGbCtD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—ERAP1—ankylosing spondylitis	0.0157	0.079	CbGpPWpGaD
Melatonin—MTNR1B—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00945	0.0476	CbGpPWpGaD
Melatonin—MTNR1A—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00945	0.0476	CbGpPWpGaD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-C—ankylosing spondylitis	0.009	0.0454	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL23R—ankylosing spondylitis	0.00847	0.0427	CbGpPWpGaD
Melatonin—CALM3—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.00594	0.03	CbGpPWpGaD
Melatonin—CALM2—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.00575	0.029	CbGpPWpGaD
Melatonin—CALM1—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.00575	0.029	CbGpPWpGaD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-B—ankylosing spondylitis	0.00532	0.0268	CbGpPWpGaD
Melatonin—CALR—Antigen Presentation: Folding, assembly and peptide loading of class I MHC—HLA-A—ankylosing spondylitis	0.00493	0.0249	CbGpPWpGaD
Melatonin—CALR—ER-Phagosome pathway—HLA-C—ankylosing spondylitis	0.00416	0.021	CbGpPWpGaD
Melatonin—CALM3—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0039	0.0197	CbGpPWpGaD
Melatonin—CALM1—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.00377	0.019	CbGpPWpGaD
Melatonin—CALM2—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.00377	0.019	CbGpPWpGaD
Melatonin—CALM3—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00377	0.019	CbGpPWpGaD
Melatonin—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00364	0.0184	CbGpPWpGaD
Melatonin—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00364	0.0184	CbGpPWpGaD
Melatonin—CALR—Antigen processing-Cross presentation—HLA-C—ankylosing spondylitis	0.00343	0.0173	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL17A—ankylosing spondylitis	0.00337	0.017	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—IL12B—ankylosing spondylitis	0.00314	0.0158	CbGpPWpGaD
Melatonin—CALR—ER-Phagosome pathway—HLA-B—ankylosing spondylitis	0.00246	0.0124	CbGpPWpGaD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—ERAP1—ankylosing spondylitis	0.00239	0.012	CbGpPWpGaD
Melatonin—CALR—ER-Phagosome pathway—HLA-A—ankylosing spondylitis	0.00228	0.0115	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00206	0.0104	CbGpPWpGaD
Melatonin—CALR—Antigen processing-Cross presentation—HLA-B—ankylosing spondylitis	0.00203	0.0102	CbGpPWpGaD
Melatonin—CALR—Antigen processing-Cross presentation—HLA-A—ankylosing spondylitis	0.00188	0.00949	CbGpPWpGaD
Melatonin—CALR—Post-translational protein modification—B3GNT2—ankylosing spondylitis	0.00176	0.00889	CbGpPWpGaD
Melatonin—MPO—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.00149	0.00752	CbGpPWpGaD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—HLA-C—ankylosing spondylitis	0.00137	0.00691	CbGpPWpGaD
Melatonin—CALR—Immune System—KIR3DL1—ankylosing spondylitis	0.00125	0.00629	CbGpPWpGaD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00123	0.00622	CbGpPWpGaD
Melatonin—MPO—Folate Metabolism—CRP—ankylosing spondylitis	0.00121	0.00612	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00118	0.00596	CbGpPWpGaD
Melatonin—MTNR1B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00117	0.00591	CbGpPWpGaD
Melatonin—MTNR1A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00117	0.00591	CbGpPWpGaD
Melatonin—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.00108	0.00544	CbGpPWpGaD
Melatonin—MTNR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.001	0.00506	CbGpPWpGaD
Melatonin—MTNR1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.001	0.00506	CbGpPWpGaD
Melatonin—MPO—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000964	0.00486	CbGpPWpGaD
Melatonin—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000914	0.00461	CbGpPWpGaD
Melatonin—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000884	0.00446	CbGpPWpGaD
Melatonin—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.000884	0.00446	CbGpPWpGaD
Melatonin—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00088	0.00444	CbGpPWpGaD
Melatonin—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00088	0.00444	CbGpPWpGaD
Melatonin—CALR—Disease—ANTXR2—ankylosing spondylitis	0.000873	0.0044	CbGpPWpGaD
Melatonin—MPO—IL23-mediated signaling events—TNF—ankylosing spondylitis	0.000872	0.0044	CbGpPWpGaD
Melatonin—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000846	0.00427	CbGpPWpGaD
Melatonin—CALR—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000836	0.00422	CbGpPWpGaD
Melatonin—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000819	0.00413	CbGpPWpGaD
Melatonin—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000819	0.00413	CbGpPWpGaD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—HLA-B—ankylosing spondylitis	0.000811	0.00409	CbGpPWpGaD
Melatonin—ESR1—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000792	0.00399	CbGpPWpGaD
Melatonin—MTNR1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000765	0.00386	CbGpPWpGaD
Melatonin—MTNR1B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000765	0.00386	CbGpPWpGaD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000759	0.00383	CbGpPWpGaD
Melatonin—CALR—Immune System—IL1R2—ankylosing spondylitis	0.000756	0.00381	CbGpPWpGaD
Melatonin—CALR—Class I MHC mediated antigen processing & presentation—HLA-A—ankylosing spondylitis	0.000751	0.00379	CbGpPWpGaD
Melatonin—ASMT—Metabolism—B3GNT2—ankylosing spondylitis	0.000738	0.00372	CbGpPWpGaD
Melatonin—SLC22A8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000723	0.00365	CbGpPWpGaD
Melatonin—CALR—Immune System—ERAP1—ankylosing spondylitis	0.000717	0.00361	CbGpPWpGaD
Melatonin—Affect lability—Betamethasone—ankylosing spondylitis	0.00068	0.00543	CcSEcCtD
Melatonin—Affect lability—Dexamethasone—ankylosing spondylitis	0.00068	0.00543	CcSEcCtD
Melatonin—Migraine—Dexamethasone—ankylosing spondylitis	0.00068	0.00543	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000679	0.00342	CbGpPWpGaD
Melatonin—MPO—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000675	0.0034	CbGpPWpGaD
Melatonin—Irritability—Betamethasone—ankylosing spondylitis	0.000659	0.00527	CcSEcCtD
Melatonin—Irritability—Dexamethasone—ankylosing spondylitis	0.000659	0.00527	CcSEcCtD
Melatonin—IDO1—Metabolism—B3GNT2—ankylosing spondylitis	0.000658	0.00332	CbGpPWpGaD
Melatonin—CALR—Immune System—CARD9—ankylosing spondylitis	0.000656	0.00331	CbGpPWpGaD
Melatonin—Mood swings—Betamethasone—ankylosing spondylitis	0.000655	0.00523	CcSEcCtD
Melatonin—Mood swings—Dexamethasone—ankylosing spondylitis	0.000655	0.00523	CcSEcCtD
Melatonin—Weight increased—Prednisolone—ankylosing spondylitis	0.000651	0.0052	CcSEcCtD
Melatonin—Dry skin—Betamethasone—ankylosing spondylitis	0.000633	0.00506	CcSEcCtD
Melatonin—Dry skin—Dexamethasone—ankylosing spondylitis	0.000633	0.00506	CcSEcCtD
Melatonin—Urine output increased—Methotrexate—ankylosing spondylitis	0.000626	0.005	CcSEcCtD
Melatonin—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.000626	0.005	CcSEcCtD
Melatonin—Lethargy—Prednisone—ankylosing spondylitis	0.000614	0.00491	CcSEcCtD
Melatonin—ESR1—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.000599	0.00302	CbGpPWpGaD
Melatonin—Weight increased—Triamcinolone—ankylosing spondylitis	0.000599	0.00479	CcSEcCtD
Melatonin—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000598	0.00478	CcSEcCtD
Melatonin—Affect lability—Prednisone—ankylosing spondylitis	0.000592	0.00473	CcSEcCtD
Melatonin—Infestation—Methylprednisolone—ankylosing spondylitis	0.000586	0.00468	CcSEcCtD
Melatonin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000586	0.00468	CcSEcCtD
Melatonin—Irritability—Prednisone—ankylosing spondylitis	0.000574	0.00459	CcSEcCtD
Melatonin—Polyuria—Methotrexate—ankylosing spondylitis	0.000573	0.00458	CcSEcCtD
Melatonin—Mood swings—Prednisone—ankylosing spondylitis	0.00057	0.00455	CcSEcCtD
Melatonin—Dry skin—Prednisone—ankylosing spondylitis	0.000552	0.00441	CcSEcCtD
Melatonin—MPO—Folate Metabolism—TNF—ankylosing spondylitis	0.000549	0.00277	CbGpPWpGaD
Melatonin—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000547	0.00276	CbGpPWpGaD
Melatonin—Weight increased—Dexamethasone—ankylosing spondylitis	0.000543	0.00434	CcSEcCtD
Melatonin—Weight increased—Betamethasone—ankylosing spondylitis	0.000543	0.00434	CcSEcCtD
Melatonin—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	0.000533	0.00269	CbGpPWpGaD
Melatonin—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000531	0.00268	CbGpPWpGaD
Melatonin—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00053	0.00267	CbGpPWpGaD
Melatonin—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00053	0.00267	CbGpPWpGaD
Melatonin—ESR1—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.000528	0.00266	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000518	0.00261	CbGpPWpGaD
Melatonin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000517	0.00413	CcSEcCtD
Melatonin—CALR—Disease—B3GNT2—ankylosing spondylitis	0.000515	0.00259	CbGpPWpGaD
Melatonin—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000514	0.00259	CbGpPWpGaD
Melatonin—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000514	0.00259	CbGpPWpGaD
Melatonin—Lethargy—Methotrexate—ankylosing spondylitis	0.000513	0.0041	CcSEcCtD
Melatonin—Erythema—Prednisolone—ankylosing spondylitis	0.000499	0.00398	CcSEcCtD
Melatonin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000491	0.00392	CcSEcCtD
Melatonin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000488	0.0039	CcSEcCtD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000484	0.00244	CbGpPWpGaD
Melatonin—Irritability—Methotrexate—ankylosing spondylitis	0.00048	0.00383	CcSEcCtD
Melatonin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000477	0.00381	CcSEcCtD
Melatonin—Mood swings—Methotrexate—ankylosing spondylitis	0.000476	0.00381	CcSEcCtD
Melatonin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000475	0.00379	CcSEcCtD
Melatonin—Weight increased—Prednisone—ankylosing spondylitis	0.000473	0.00378	CcSEcCtD
Melatonin—Vision blurred—Prednisolone—ankylosing spondylitis	0.00047	0.00375	CcSEcCtD
Melatonin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000464	0.00371	CcSEcCtD
Melatonin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000461	0.00368	CcSEcCtD
Melatonin—Erythema—Triamcinolone—ankylosing spondylitis	0.000459	0.00366	CcSEcCtD
Melatonin—Erythema—Methylprednisolone—ankylosing spondylitis	0.000458	0.00366	CcSEcCtD
Melatonin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000458	0.00366	CcSEcCtD
Melatonin—Angioedema—Prednisolone—ankylosing spondylitis	0.000456	0.00364	CcSEcCtD
Melatonin—Breast disorder—Methotrexate—ankylosing spondylitis	0.000454	0.00363	CcSEcCtD
Melatonin—Vertigo—Prednisolone—ankylosing spondylitis	0.000448	0.00358	CcSEcCtD
Melatonin—Syncope—Prednisolone—ankylosing spondylitis	0.000447	0.00357	CcSEcCtD
Melatonin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000447	0.00357	CcSEcCtD
Melatonin—Eye disorder—Betamethasone—ankylosing spondylitis	0.000447	0.00357	CcSEcCtD
Melatonin—Back pain—Triamcinolone—ankylosing spondylitis	0.000444	0.00354	CcSEcCtD
Melatonin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000438	0.0035	CcSEcCtD
Melatonin—MPO—Selenium Micronutrient Network—TNF—ankylosing spondylitis	0.000436	0.0022	CbGpPWpGaD
Melatonin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000434	0.00347	CcSEcCtD
Melatonin—Angiopathy—Betamethasone—ankylosing spondylitis	0.000434	0.00347	CcSEcCtD
Melatonin—MTNR1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000432	0.00218	CbGpPWpGaD
Melatonin—MTNR1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000432	0.00218	CbGpPWpGaD
Melatonin—Hypertension—Prednisolone—ankylosing spondylitis	0.000431	0.00344	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000422	0.00213	CbGpPWpGaD
Melatonin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000419	0.00335	CcSEcCtD
Melatonin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000418	0.00334	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000417	0.00333	CcSEcCtD
Melatonin—Erythema—Dexamethasone—ankylosing spondylitis	0.000416	0.00332	CcSEcCtD
Melatonin—Erythema—Betamethasone—ankylosing spondylitis	0.000416	0.00332	CcSEcCtD
Melatonin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000412	0.00329	CcSEcCtD
Melatonin—CALR—Immune System—HLA-C—ankylosing spondylitis	0.000412	0.00208	CbGpPWpGaD
Melatonin—Syncope—Triamcinolone—ankylosing spondylitis	0.000411	0.00329	CcSEcCtD
Melatonin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000411	0.00328	CcSEcCtD
Melatonin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00041	0.00328	CcSEcCtD
Melatonin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000409	0.00327	CcSEcCtD
Melatonin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000403	0.00322	CcSEcCtD
Melatonin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000402	0.00321	CcSEcCtD
Melatonin—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000402	0.00203	CbGpPWpGaD
Melatonin—CALR—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000401	0.00202	CbGpPWpGaD
Melatonin—Shock—Prednisolone—ankylosing spondylitis	0.0004	0.0032	CcSEcCtD
Melatonin—Hypertension—Triamcinolone—ankylosing spondylitis	0.000396	0.00316	CcSEcCtD
Melatonin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000395	0.00316	CcSEcCtD
Melatonin—MTNR1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000392	0.00198	CbGpPWpGaD
Melatonin—MTNR1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000392	0.00198	CbGpPWpGaD
Melatonin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00039	0.00311	CcSEcCtD
Melatonin—Eye disorder—Prednisone—ankylosing spondylitis	0.000389	0.00311	CcSEcCtD
Melatonin—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000389	0.00196	CbGpPWpGaD
Melatonin—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.000389	0.00196	CbGpPWpGaD
Melatonin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000388	0.0031	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000388	0.0031	CcSEcCtD
Melatonin—Infestation—Methotrexate—ankylosing spondylitis	0.000388	0.0031	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000387	0.00309	CcSEcCtD
Melatonin—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000386	0.00195	CbGpPWpGaD
Melatonin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000382	0.00305	CcSEcCtD
Melatonin—Angioedema—Betamethasone—ankylosing spondylitis	0.00038	0.00304	CcSEcCtD
Melatonin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00038	0.00304	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000378	0.00302	CcSEcCtD
Melatonin—Angiopathy—Prednisone—ankylosing spondylitis	0.000378	0.00302	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000376	0.003	CcSEcCtD
Melatonin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000374	0.00299	CcSEcCtD
Melatonin—Vertigo—Betamethasone—ankylosing spondylitis	0.000374	0.00299	CcSEcCtD
Melatonin—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000374	0.00188	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000374	0.00188	CbGpPWpGaD
Melatonin—Syncope—Betamethasone—ankylosing spondylitis	0.000373	0.00298	CcSEcCtD
Melatonin—Syncope—Dexamethasone—ankylosing spondylitis	0.000373	0.00298	CcSEcCtD
Melatonin—CALR—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000372	0.00188	CbGpPWpGaD
Melatonin—Infection—Triamcinolone—ankylosing spondylitis	0.000372	0.00297	CcSEcCtD
Melatonin—Infection—Methylprednisolone—ankylosing spondylitis	0.000371	0.00296	CcSEcCtD
Melatonin—Haematuria—Methotrexate—ankylosing spondylitis	0.00037	0.00295	CcSEcCtD
Melatonin—Shock—Triamcinolone—ankylosing spondylitis	0.000368	0.00294	CcSEcCtD
Melatonin—Insomnia—Prednisolone—ankylosing spondylitis	0.000368	0.00294	CcSEcCtD
Melatonin—Shock—Methylprednisolone—ankylosing spondylitis	0.000367	0.00294	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000367	0.00293	CcSEcCtD
Melatonin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000366	0.00293	CcSEcCtD
Melatonin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000366	0.00292	CcSEcCtD
Melatonin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000366	0.00292	CcSEcCtD
Melatonin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000365	0.00292	CcSEcCtD
Melatonin—Mental disorder—Prednisone—ankylosing spondylitis	0.000365	0.00291	CcSEcCtD
Melatonin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000363	0.0029	CcSEcCtD
Melatonin—Malnutrition—Prednisone—ankylosing spondylitis	0.000362	0.0029	CcSEcCtD
Melatonin—Erythema—Prednisone—ankylosing spondylitis	0.000362	0.0029	CcSEcCtD
Melatonin—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000362	0.00183	CbGpPWpGaD
Melatonin—Hypertension—Betamethasone—ankylosing spondylitis	0.000359	0.00287	CcSEcCtD
Melatonin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000359	0.00287	CcSEcCtD
Melatonin—CALR—Immune System—IL1RN—ankylosing spondylitis	0.000358	0.0018	CbGpPWpGaD
Melatonin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000353	0.00282	CcSEcCtD
Melatonin—Anxiety—Betamethasone—ankylosing spondylitis	0.000353	0.00282	CcSEcCtD
Melatonin—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00035	0.00177	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00035	0.00177	CbGpPWpGaD
Melatonin—Pain—Prednisolone—ankylosing spondylitis	0.000348	0.00278	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000344	0.00275	CcSEcCtD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000343	0.00173	CbGpPWpGaD
Melatonin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000343	0.00173	CbGpPWpGaD
Melatonin—Vision blurred—Prednisone—ankylosing spondylitis	0.000342	0.00273	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000341	0.00272	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000341	0.00272	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00034	0.00272	CcSEcCtD
Melatonin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000339	0.0027	CcSEcCtD
Melatonin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000338	0.0027	CcSEcCtD
Melatonin—Infection—Dexamethasone—ankylosing spondylitis	0.000337	0.0027	CcSEcCtD
Melatonin—Infection—Betamethasone—ankylosing spondylitis	0.000337	0.0027	CcSEcCtD
Melatonin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000336	0.00269	CcSEcCtD
Melatonin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000335	0.00268	CcSEcCtD
Melatonin—Shock—Dexamethasone—ankylosing spondylitis	0.000334	0.00267	CcSEcCtD
Melatonin—Shock—Betamethasone—ankylosing spondylitis	0.000334	0.00267	CcSEcCtD
Melatonin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000333	0.00266	CcSEcCtD
Melatonin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000333	0.00266	CcSEcCtD
Melatonin—Agitation—Prednisone—ankylosing spondylitis	0.000333	0.00266	CcSEcCtD
Melatonin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000333	0.00266	CcSEcCtD
Melatonin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000333	0.00266	CcSEcCtD
Melatonin—Angioedema—Prednisone—ankylosing spondylitis	0.000331	0.00265	CcSEcCtD
Melatonin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000329	0.00263	CcSEcCtD
Melatonin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000329	0.00263	CcSEcCtD
Melatonin—Vertigo—Prednisone—ankylosing spondylitis	0.000326	0.0026	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000325	0.0026	CcSEcCtD
Melatonin—Syncope—Prednisone—ankylosing spondylitis	0.000325	0.0026	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000323	0.00258	CcSEcCtD
Melatonin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000323	0.00258	CcSEcCtD
Melatonin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000322	0.00257	CcSEcCtD
Melatonin—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00032	0.00161	CbGpPWpGaD
Melatonin—Pain—Triamcinolone—ankylosing spondylitis	0.00032	0.00256	CcSEcCtD
Melatonin—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00032	0.00161	CbGpPWpGaD
Melatonin—ESR1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000319	0.00161	CbGpPWpGaD
Melatonin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000318	0.00254	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000316	0.00252	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000314	0.00251	CcSEcCtD
Melatonin—CALR—Immune System—CD79A—ankylosing spondylitis	0.000314	0.00158	CbGpPWpGaD
Melatonin—Hypertension—Prednisone—ankylosing spondylitis	0.000313	0.0025	CcSEcCtD
Melatonin—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00031	0.00156	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00031	0.00156	CbGpPWpGaD
Melatonin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000309	0.00247	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000309	0.00247	CcSEcCtD
Melatonin—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000309	0.00156	CbGpPWpGaD
Melatonin—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000309	0.00156	CbGpPWpGaD
Melatonin—Arthralgia—Prednisone—ankylosing spondylitis	0.000309	0.00246	CcSEcCtD
Melatonin—Anxiety—Prednisone—ankylosing spondylitis	0.000307	0.00246	CcSEcCtD
Melatonin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000307	0.00245	CcSEcCtD
Melatonin—Insomnia—Betamethasone—ankylosing spondylitis	0.000307	0.00245	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000306	0.00245	CcSEcCtD
Melatonin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000305	0.00244	CcSEcCtD
Melatonin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000305	0.00244	CcSEcCtD
Melatonin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000305	0.00244	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000305	0.00244	CcSEcCtD
Melatonin—Erythema—Methotrexate—ankylosing spondylitis	0.000303	0.00242	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000303	0.00242	CcSEcCtD
Melatonin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0003	0.0024	CcSEcCtD
Melatonin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000299	0.00239	CcSEcCtD
Melatonin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000299	0.00239	CcSEcCtD
Melatonin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000295	0.00236	CcSEcCtD
Melatonin—Infection—Prednisone—ankylosing spondylitis	0.000294	0.00235	CcSEcCtD
Melatonin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000293	0.00234	CcSEcCtD
Melatonin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000293	0.00234	CcSEcCtD
Melatonin—Back pain—Methotrexate—ankylosing spondylitis	0.000293	0.00234	CcSEcCtD
Melatonin—Fatigue—Betamethasone—ankylosing spondylitis	0.000293	0.00234	CcSEcCtD
Melatonin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000293	0.00234	CcSEcCtD
Melatonin—Shock—Prednisone—ankylosing spondylitis	0.000291	0.00232	CcSEcCtD
Melatonin—Pain—Betamethasone—ankylosing spondylitis	0.00029	0.00232	CcSEcCtD
Melatonin—Pain—Dexamethasone—ankylosing spondylitis	0.00029	0.00232	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00029	0.00232	CcSEcCtD
Melatonin—Skin disorder—Prednisone—ankylosing spondylitis	0.000287	0.0023	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000285	0.00228	CcSEcCtD
Melatonin—MTNR1B—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000279	0.00141	CbGpPWpGaD
Melatonin—MTNR1A—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000279	0.00141	CbGpPWpGaD
Melatonin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000278	0.00222	CcSEcCtD
Melatonin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000278	0.00222	CcSEcCtD
Melatonin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000276	0.0022	CcSEcCtD
Melatonin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000275	0.0022	CcSEcCtD
Melatonin—Vertigo—Methotrexate—ankylosing spondylitis	0.000272	0.00217	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000271	0.00217	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000269	0.00215	CcSEcCtD
Melatonin—Dizziness—Prednisolone—ankylosing spondylitis	0.000269	0.00215	CcSEcCtD
Melatonin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000269	0.00215	CcSEcCtD
Melatonin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000268	0.00214	CcSEcCtD
Melatonin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000268	0.00214	CcSEcCtD
Melatonin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000268	0.00214	CcSEcCtD
Melatonin—Insomnia—Prednisone—ankylosing spondylitis	0.000267	0.00214	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000266	0.00212	CcSEcCtD
Melatonin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000265	0.00212	CcSEcCtD
Melatonin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000264	0.00211	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00026	0.00208	CcSEcCtD
Melatonin—Chest pain—Methotrexate—ankylosing spondylitis	0.000258	0.00206	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000258	0.00206	CcSEcCtD
Melatonin—CALR—Immune System—IL1A—ankylosing spondylitis	0.000257	0.0013	CbGpPWpGaD
Melatonin—Rash—Prednisolone—ankylosing spondylitis	0.000257	0.00205	CcSEcCtD
Melatonin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000256	0.00205	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000256	0.00205	CcSEcCtD
Melatonin—CALR—Immune System—CD40LG—ankylosing spondylitis	0.000256	0.00129	CbGpPWpGaD
Melatonin—Fatigue—Prednisone—ankylosing spondylitis	0.000255	0.00204	CcSEcCtD
Melatonin—Headache—Prednisolone—ankylosing spondylitis	0.000255	0.00204	CcSEcCtD
Melatonin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000248	0.00198	CcSEcCtD
Melatonin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000247	0.00197	CcSEcCtD
Melatonin—Infection—Methotrexate—ankylosing spondylitis	0.000246	0.00196	CcSEcCtD
Melatonin—Asthenia—Betamethasone—ankylosing spondylitis	0.000244	0.00195	CcSEcCtD
Melatonin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000244	0.00195	CcSEcCtD
Melatonin—CALR—Immune System—HLA-B—ankylosing spondylitis	0.000243	0.00123	CbGpPWpGaD
Melatonin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000242	0.00194	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000242	0.00193	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000242	0.00193	CcSEcCtD
Melatonin—Nausea—Prednisolone—ankylosing spondylitis	0.000242	0.00193	CcSEcCtD
Melatonin—Pruritus—Betamethasone—ankylosing spondylitis	0.00024	0.00192	CcSEcCtD
Melatonin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00024	0.00192	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00024	0.00192	CcSEcCtD
Melatonin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000238	0.0019	CcSEcCtD
Melatonin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000237	0.0019	CcSEcCtD
Melatonin—Rash—Triamcinolone—ankylosing spondylitis	0.000236	0.00189	CcSEcCtD
Melatonin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000236	0.00188	CcSEcCtD
Melatonin—Rash—Methylprednisolone—ankylosing spondylitis	0.000235	0.00188	CcSEcCtD
Melatonin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000235	0.00188	CcSEcCtD
Melatonin—Headache—Triamcinolone—ankylosing spondylitis	0.000234	0.00187	CcSEcCtD
Melatonin—Headache—Methylprednisolone—ankylosing spondylitis	0.000234	0.00187	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000234	0.00187	CcSEcCtD
Melatonin—MTNR1B—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000232	0.00117	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000232	0.00117	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.000226	0.00114	CbGpPWpGaD
Melatonin—CALR—Immune System—HLA-A—ankylosing spondylitis	0.000226	0.00114	CbGpPWpGaD
Melatonin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000225	0.0018	CcSEcCtD
Melatonin—Dizziness—Betamethasone—ankylosing spondylitis	0.000225	0.00179	CcSEcCtD
Melatonin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000225	0.00179	CcSEcCtD
Melatonin—Insomnia—Methotrexate—ankylosing spondylitis	0.000224	0.00179	CcSEcCtD
Melatonin—Nausea—Triamcinolone—ankylosing spondylitis	0.000222	0.00178	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000222	0.00177	CcSEcCtD
Melatonin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000222	0.00177	CcSEcCtD
Melatonin—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.00022	0.00111	CbGpPWpGaD
Melatonin—Somnolence—Methotrexate—ankylosing spondylitis	0.00022	0.00176	CcSEcCtD
Melatonin—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000219	0.0011	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000219	0.0011	CbGpPWpGaD
Melatonin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000218	0.00174	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000218	0.00174	CcSEcCtD
Melatonin—Vomiting—Betamethasone—ankylosing spondylitis	0.000216	0.00173	CcSEcCtD
Melatonin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000216	0.00173	CcSEcCtD
Melatonin—CALR—Immune System—CRP—ankylosing spondylitis	0.000215	0.00108	CbGpPWpGaD
Melatonin—Rash—Betamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Melatonin—Rash—Dexamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Melatonin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Melatonin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000214	0.00171	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000213	0.0017	CcSEcCtD
Melatonin—Fatigue—Methotrexate—ankylosing spondylitis	0.000213	0.0017	CcSEcCtD
Melatonin—Headache—Betamethasone—ankylosing spondylitis	0.000213	0.0017	CcSEcCtD
Melatonin—Headache—Dexamethasone—ankylosing spondylitis	0.000213	0.0017	CcSEcCtD
Melatonin—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000213	0.00107	CbGpPWpGaD
Melatonin—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000213	0.00107	CbGpPWpGaD
Melatonin—Asthenia—Prednisone—ankylosing spondylitis	0.000212	0.0017	CcSEcCtD
Melatonin—Pain—Methotrexate—ankylosing spondylitis	0.000211	0.00169	CcSEcCtD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000211	0.00107	CbGpPWpGaD
Melatonin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000211	0.00107	CbGpPWpGaD
Melatonin—Pruritus—Prednisone—ankylosing spondylitis	0.000209	0.00167	CcSEcCtD
Melatonin—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000208	0.00105	CbGpPWpGaD
Melatonin—CALR—Disease—HLA-A—ankylosing spondylitis	0.000208	0.00105	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000208	0.00105	CbGpPWpGaD
Melatonin—CALR—Immune System—TLR4—ankylosing spondylitis	0.000206	0.00104	CbGpPWpGaD
Melatonin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000202	0.00161	CcSEcCtD
Melatonin—Nausea—Dexamethasone—ankylosing spondylitis	0.000202	0.00161	CcSEcCtD
Melatonin—Nausea—Betamethasone—ankylosing spondylitis	0.000202	0.00161	CcSEcCtD
Melatonin—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000202	0.00102	CbGpPWpGaD
Melatonin—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000202	0.00102	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000201	0.00101	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000201	0.00101	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000198	0.000999	CbGpPWpGaD
Melatonin—Dizziness—Prednisone—ankylosing spondylitis	0.000196	0.00156	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000195	0.00156	CcSEcCtD
Melatonin—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000192	0.000967	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000192	0.000967	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000189	0.000955	CbGpPWpGaD
Melatonin—Vomiting—Prednisone—ankylosing spondylitis	0.000188	0.0015	CcSEcCtD
Melatonin—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000187	0.000942	CbGpPWpGaD
Melatonin—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000187	0.000942	CbGpPWpGaD
Melatonin—Rash—Prednisone—ankylosing spondylitis	0.000186	0.00149	CcSEcCtD
Melatonin—Dermatitis—Prednisone—ankylosing spondylitis	0.000186	0.00149	CcSEcCtD
Melatonin—Headache—Prednisone—ankylosing spondylitis	0.000185	0.00148	CcSEcCtD
Melatonin—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000183	0.000924	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000183	0.000924	CbGpPWpGaD
Melatonin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000182	0.00145	CcSEcCtD
Melatonin—Asthenia—Methotrexate—ankylosing spondylitis	0.000177	0.00142	CcSEcCtD
Melatonin—Nausea—Prednisone—ankylosing spondylitis	0.000176	0.0014	CcSEcCtD
Melatonin—Pruritus—Methotrexate—ankylosing spondylitis	0.000175	0.0014	CcSEcCtD
Melatonin—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000167	0.000841	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—MMP3—ankylosing spondylitis	0.000165	0.000832	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—MMP3—ankylosing spondylitis	0.000165	0.000832	CbGpPWpGaD
Melatonin—Dizziness—Methotrexate—ankylosing spondylitis	0.000163	0.00131	CcSEcCtD
Melatonin—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000161	0.000814	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000161	0.000814	CbGpPWpGaD
Melatonin—Vomiting—Methotrexate—ankylosing spondylitis	0.000157	0.00126	CcSEcCtD
Melatonin—Rash—Methotrexate—ankylosing spondylitis	0.000156	0.00125	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000156	0.00124	CcSEcCtD
Melatonin—Headache—Methotrexate—ankylosing spondylitis	0.000155	0.00124	CcSEcCtD
Melatonin—CALM3—Disease—ANTXR2—ankylosing spondylitis	0.000154	0.000775	CbGpPWpGaD
Melatonin—CALM2—Disease—ANTXR2—ankylosing spondylitis	0.000149	0.00075	CbGpPWpGaD
Melatonin—CALM1—Disease—ANTXR2—ankylosing spondylitis	0.000149	0.00075	CbGpPWpGaD
Melatonin—Nausea—Methotrexate—ankylosing spondylitis	0.000147	0.00117	CcSEcCtD
Melatonin—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	0.000145	0.000729	CbGpPWpGaD
Melatonin—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	0.00014	0.000705	CbGpPWpGaD
Melatonin—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	0.00014	0.000705	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000135	0.000679	CbGpPWpGaD
Melatonin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000135	0.000679	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1R2—ankylosing spondylitis	0.000133	0.000671	CbGpPWpGaD
Melatonin—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000133	0.000671	CbGpPWpGaD
Melatonin—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000133	0.000671	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1R2—ankylosing spondylitis	0.000129	0.000649	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1R2—ankylosing spondylitis	0.000129	0.000649	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERAP1—ankylosing spondylitis	0.000126	0.000636	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	0.000124	0.000627	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERAP1—ankylosing spondylitis	0.000122	0.000616	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERAP1—ankylosing spondylitis	0.000122	0.000616	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—B3GNT2—ankylosing spondylitis	0.000121	0.000612	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00012	0.000607	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	0.00012	0.000607	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00012	0.000603	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	0.000117	0.00059	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000116	0.000583	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000116	0.000583	CbGpPWpGaD
Melatonin—CALM3—Immune System—CARD9—ankylosing spondylitis	0.000115	0.000582	CbGpPWpGaD
Melatonin—CALM2—Immune System—CARD9—ankylosing spondylitis	0.000112	0.000563	CbGpPWpGaD
Melatonin—CALM1—Immune System—CARD9—ankylosing spondylitis	0.000112	0.000563	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000102	0.000515	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	9.11e-05	0.00046	CbGpPWpGaD
Melatonin—CALM3—Disease—B3GNT2—ankylosing spondylitis	9.06e-05	0.000457	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	8.82e-05	0.000445	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	8.82e-05	0.000445	CbGpPWpGaD
Melatonin—CALM2—Disease—B3GNT2—ankylosing spondylitis	8.77e-05	0.000442	CbGpPWpGaD
Melatonin—CALM1—Disease—B3GNT2—ankylosing spondylitis	8.77e-05	0.000442	CbGpPWpGaD
Melatonin—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	7.59e-05	0.000383	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.43e-05	0.000375	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.37e-05	0.000371	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	7.36e-05	0.000371	CbGpPWpGaD
Melatonin—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	7.34e-05	0.00037	CbGpPWpGaD
Melatonin—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	7.34e-05	0.00037	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-C—ankylosing spondylitis	7.25e-05	0.000365	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	7.2e-05	0.000363	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.19e-05	0.000362	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.19e-05	0.000362	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.13e-05	0.000359	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.13e-05	0.000359	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	7.12e-05	0.000359	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	7.12e-05	0.000359	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	7.07e-05	0.000356	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-C—ankylosing spondylitis	7.01e-05	0.000354	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-C—ankylosing spondylitis	7.01e-05	0.000354	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.84e-05	0.000345	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.84e-05	0.000345	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.55e-05	0.00033	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CRP—ankylosing spondylitis	6.51e-05	0.000328	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.33e-05	0.000319	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.33e-05	0.000319	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1RN—ankylosing spondylitis	6.3e-05	0.000317	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CRP—ankylosing spondylitis	6.29e-05	0.000317	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CRP—ankylosing spondylitis	6.29e-05	0.000317	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	6.24e-05	0.000314	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTGER4—ankylosing spondylitis	6.23e-05	0.000314	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1RN—ankylosing spondylitis	6.09e-05	0.000307	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1RN—ankylosing spondylitis	6.09e-05	0.000307	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	6.03e-05	0.000304	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	6.03e-05	0.000304	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	5.89e-05	0.000297	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD79A—ankylosing spondylitis	5.53e-05	0.000279	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	5.37e-05	0.000271	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD79A—ankylosing spondylitis	5.35e-05	0.00027	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD79A—ankylosing spondylitis	5.35e-05	0.00027	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	5.25e-05	0.000265	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.07e-05	0.000256	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	5.07e-05	0.000256	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	4.59e-05	0.000231	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL1A—ankylosing spondylitis	4.53e-05	0.000229	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD40LG—ankylosing spondylitis	4.51e-05	0.000227	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP3—ankylosing spondylitis	4.44e-05	0.000224	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL1A—ankylosing spondylitis	4.38e-05	0.000221	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL1A—ankylosing spondylitis	4.38e-05	0.000221	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD40LG—ankylosing spondylitis	4.36e-05	0.00022	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD40LG—ankylosing spondylitis	4.36e-05	0.00022	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	4.35e-05	0.000219	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-B—ankylosing spondylitis	4.29e-05	0.000216	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.21e-05	0.000212	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	4.21e-05	0.000212	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-B—ankylosing spondylitis	4.15e-05	0.000209	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-B—ankylosing spondylitis	4.15e-05	0.000209	CbGpPWpGaD
Melatonin—CALM3—Immune System—HLA-A—ankylosing spondylitis	3.97e-05	0.0002	CbGpPWpGaD
Melatonin—CALM2—Immune System—HLA-A—ankylosing spondylitis	3.84e-05	0.000194	CbGpPWpGaD
Melatonin—CALM1—Immune System—HLA-A—ankylosing spondylitis	3.84e-05	0.000194	CbGpPWpGaD
Melatonin—CALM3—Immune System—CRP—ankylosing spondylitis	3.79e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—Disease—HLA-A—ankylosing spondylitis	3.67e-05	0.000185	CbGpPWpGaD
Melatonin—CALM2—Immune System—CRP—ankylosing spondylitis	3.67e-05	0.000185	CbGpPWpGaD
Melatonin—CALM1—Immune System—CRP—ankylosing spondylitis	3.67e-05	0.000185	CbGpPWpGaD
Melatonin—CALM3—Immune System—TLR4—ankylosing spondylitis	3.63e-05	0.000183	CbGpPWpGaD
Melatonin—CALM1—Disease—HLA-A—ankylosing spondylitis	3.55e-05	0.000179	CbGpPWpGaD
Melatonin—CALM2—Disease—HLA-A—ankylosing spondylitis	3.55e-05	0.000179	CbGpPWpGaD
Melatonin—CALM2—Immune System—TLR4—ankylosing spondylitis	3.51e-05	0.000177	CbGpPWpGaD
Melatonin—CALM1—Immune System—TLR4—ankylosing spondylitis	3.51e-05	0.000177	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	3.1e-05	0.000156	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	3e-05	0.000151	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	3e-05	0.000151	CbGpPWpGaD
